Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/7174
Title: | An ovine septic shock model of live bacterial infusion | Authors: | Obonyo, Nchafatso G. Raman, Sainath Suen, Jacky Y. Peters, Kate M. Phan, Minh-Duy Passmore, Margaret R. Bouquet, Mahe Wilson, Emily S. Hyslop, Kieran Palmieri, Chiara White, Nicole Sato, Kei Farah, Samia M. Gandini, Lucia Liu, Keibun Fior, Gabriele Heinsar, Silver Ijuin, Shinichi Kyun Ro, Sun Abbate, Gabriella Ainola, Carmen Sato, Noriko Lundon, Brooke Portatadino, Sofia Rachakonda, Reema H. Schneider, Bailey Harley, Amanda See Hoe, Louise E. Schembri, Mark A. Li Bassi, Gianluigi Fraser, John F. |
Issue Date: | 2024 | Source: | Intensive care medicine experimental, 2024 (12) 1 p.94 | Pages: | 94 | Journal Title: | Intensive care medicine experimental | Abstract: | Background: Escherichia coli is the most common cause of human bloodstream infections and bacterial sepsis/septic shock. However, translation of preclinical septic shock resuscitative therapies remains limited mainly due to low-fidelity of available models in mimicking clinical illness. To overcome the translational barrier, we sought to replicate sepsis complexity by creating an acutely critically-ill preclinical bacterial septic shock model undergoing active 48-h intensive care management.; Aim: To develop a clinically relevant large-animal (ovine) live-bacterial infusion model for septic shock.; Methods: Septic shock was induced by intravenous infusion of the live antibiotic resistant extra-intestinal pathogenic E. coli sequence type 131 strain EC958 in eight anesthetised and mechanically ventilated sheep. A bacterial dose range of 2 × 10 5 -2 × 10 9 cfu/mL was used for the dose optimisation phase (n = 4) and upon dose confirmation the model was developed (n = 5). Post-shock the animals underwent an early-vasopressor and volume-restriction resuscitation strategy with active haemodynamic management and monitoring over 48 h. Serial blood samples were collected for testing of pro-inflammatory (IL-6, IL-8, VEGFA) and anti-inflammatory (IL-10) cytokines and hyaluronan assay to assess endothelial integrity. Tissue samples were collected for histopathology and transmission electron microscopy.; Results: The 2 × 10 7 cfu/mL bacterial dose led to a reproducible distributive shock within a pre-determined 12-h period. Five sheep were used to demonstrate consistency of the model. Bacterial infusion led to development of septic shock in all animals. The baseline mean arterial blood pressure reduced from a median of 91 mmHg (71, 102) to 50 mmHg (48, 57) (p = 0.004) and lactate levels increased from a median of 0.5 mM (0.3, 0.8) to 2.1 mM (2.0, 2.3) (p = 0.02) post-shock. The baseline median hyaluronan levels increased significantly from 25 ng/mL (18, 86) to 168 ng/mL (86, 569), p = 0.05 but not the median vasopressor dependency index which increased within 1 h of resuscitation from zero to 0.39 mmHg -1 (0.06, 5.13), p = 0.065, and. Over the 48 h, there was a significant decrease in the systemic vascular resistance index (F = 7.46, p = 0.01) and increase in the pro-inflammatory cytokines [IL-6 (F = 8.90, p = 0.02), IL-8 (F = 5.28, p = 0.03), and VEGFA (F = 6.47, p = 0.02)].; Conclusions: This critically ill large-animal model was consistent in reproducing septic shock and will be applied in investigating advanced resuscitation and therapeutic interventions. (© 2024. The Author(s).) | DOI: | 10.1186/s40635-024-00684-x | Resources: | https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,athens&db=mdc&AN=39467921&site=ehost-live |
Appears in Sites: | Children's Health Queensland Publications Queensland Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.